Tags

Type your tag names separated by a space and hit enter

Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients.
Clin Res Hepatol Gastroenterol. 2020 Jun 24 [Online ahead of print]CR

Abstract

BACKGROUND

Transarterial chemoembolization (TACE) is widely applied in hepatocellular carcinoma (HCC) patients who are not suitable for surgical treatment. We aimed to investigate the treatment outcomes and comprehensive prognostic factors of CalliSpheres® microspheres (CSM) drug-eluting bead TACE (DEB-TACE) treatment and conventional TACE (cTACE) treatment in HCC patients.

METHODS

Three hundred and thirty-five HCC patients received DEB-TACE or cTACE treatment were consecutively enrolled in multi-center, retrospective cohort study. Treatment response was conducted at M1, M3 or M6 after treatment. Progression free survival (PFS) and overall survival (OS) were recorded. Thirty-seven baseline factors including demographic characteristics, clinical features, biochemical indexes and previous treatment histories were selected.

RESULTS

In total patients, history of drink and largest nodule size≥7cm independently predicted worse ORR, DEB-TACE predicted better OS, while largest nodule size≥7cm, increased Child-Pugh stage, ALB abnormal, ALP abnormal or AFP abnormal predicted worse survival. For DEB-TACE group, previous cTACE and ANC abnormal independently predicted worse ORR, and hepatic vein invasion, increased Child-Pugh stage or AFP abnormal independently predicted poor survival. For cTACE group, largest nodule size≥7cm independently predicted poor ORR, and multifocal disease as well as ALB abnormal predicted poor OS.

CONCLUSIONS

History of drink, largest nodule size≥7cm, DEB-TACE, increased Child-Pugh stage, abnormal ALB, ALP or AFP are potential prognostic factors in total patients, previous cTACE and ANC abnormal, hepatic vein invasion, increased Child-Pugh stage or AFP abnormal are potential prognostic factors in DEB-TA group, and largest nodule size≥7cm, multifocal disease and ALB abnormal are potential prognostic factors in cTACE group.

Authors+Show Affiliations

Department of Radiology, Xiangya Hospital Central South University, Changsha, China.Department of Radiology, Wuhan General Hospita of Guangzhou Military, 627 Wuluo Road, Wuhan 430070, China. Electronic address: meiranhuaniw@163.com.Department of Intervention, Hunan Provincial People's Hospital, Changsha, China.Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China.Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China.Department of Interventional Therapy, Guangxi Medical University Affiliated Tumor Hospital, Nanning, China.Department of Interventional Therapy, Guangxi Medical University Affiliated Tumor Hospital, Nanning, China.Department of Intervention, Hunan Provincial People's Hospital, Changsha, China.Department of Interventional Radiology,Department of Radiology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan 430060, China.Department of Interventional Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.Department of Interventional Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.Department of Radiology, Xiangya Hospital Central South University, Changsha, China.Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.Department of Radiology, Wuhan General Hospita of Guangzhou Military, 627 Wuluo Road, Wuhan 430070, China.Department of Interventional Radiology,Department of Radiology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan 430060, China. Electronic address: huhongyao@vip.163.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32593695

Citation

Chen, Changyong, et al. "Comprehensive Predictive Factors for CalliSpheres® Microspheres (CSM) Drug-eluting Bead-transarterial Chemoembolization and Conventional Transarterial Chemoembolization On Treatment Response and Survival in Hepatocellular Carcinoma Patients." Clinics and Research in Hepatology and Gastroenterology, 2020.
Chen C, Qiu H, Yao Y, et al. Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients. Clin Res Hepatol Gastroenterol. 2020.
Chen, C., Qiu, H., Yao, Y., Zhang, Z., Ma, C., Ma, Y., Zhao, C., Xiang, H., Zhao, H., Zheng, C., Xiong, B., Li, H., Long, Q., Zhou, J., Luo, C., & Hu, H. (2020). Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients. Clinics and Research in Hepatology and Gastroenterology. https://doi.org/10.1016/j.clinre.2020.05.008
Chen C, et al. Comprehensive Predictive Factors for CalliSpheres® Microspheres (CSM) Drug-eluting Bead-transarterial Chemoembolization and Conventional Transarterial Chemoembolization On Treatment Response and Survival in Hepatocellular Carcinoma Patients. Clin Res Hepatol Gastroenterol. 2020 Jun 24; PubMed PMID: 32593695.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients. AU - Chen,Changyong, AU - Qiu,Huaiming, AU - Yao,Yuanhui, AU - Zhang,Zishu, AU - Ma,Cong, AU - Ma,Yilong, AU - Zhao,Chang, AU - Xiang,Hua, AU - Zhao,Hui, AU - Zheng,Chuansheng, AU - Xiong,Bin, AU - Li,Haiping, AU - Long,Qingyun, AU - Zhou,Jun, AU - Luo,Chao, AU - Hu,Hongyao, Y1 - 2020/06/24/ PY - 2020/03/19/received PY - 2020/05/12/revised PY - 2020/05/26/accepted PY - 2020/6/29/entrez KW - Conventional transarterial chemoembolization KW - Drug-eluting bead-transarterial chemoembolization KW - Hepatocellular carcinoma KW - Prognostic factors KW - Survival KW - Treatment response JF - Clinics and research in hepatology and gastroenterology JO - Clin Res Hepatol Gastroenterol N2 - BACKGROUND: Transarterial chemoembolization (TACE) is widely applied in hepatocellular carcinoma (HCC) patients who are not suitable for surgical treatment. We aimed to investigate the treatment outcomes and comprehensive prognostic factors of CalliSpheres® microspheres (CSM) drug-eluting bead TACE (DEB-TACE) treatment and conventional TACE (cTACE) treatment in HCC patients. METHODS: Three hundred and thirty-five HCC patients received DEB-TACE or cTACE treatment were consecutively enrolled in multi-center, retrospective cohort study. Treatment response was conducted at M1, M3 or M6 after treatment. Progression free survival (PFS) and overall survival (OS) were recorded. Thirty-seven baseline factors including demographic characteristics, clinical features, biochemical indexes and previous treatment histories were selected. RESULTS: In total patients, history of drink and largest nodule size≥7cm independently predicted worse ORR, DEB-TACE predicted better OS, while largest nodule size≥7cm, increased Child-Pugh stage, ALB abnormal, ALP abnormal or AFP abnormal predicted worse survival. For DEB-TACE group, previous cTACE and ANC abnormal independently predicted worse ORR, and hepatic vein invasion, increased Child-Pugh stage or AFP abnormal independently predicted poor survival. For cTACE group, largest nodule size≥7cm independently predicted poor ORR, and multifocal disease as well as ALB abnormal predicted poor OS. CONCLUSIONS: History of drink, largest nodule size≥7cm, DEB-TACE, increased Child-Pugh stage, abnormal ALB, ALP or AFP are potential prognostic factors in total patients, previous cTACE and ANC abnormal, hepatic vein invasion, increased Child-Pugh stage or AFP abnormal are potential prognostic factors in DEB-TA group, and largest nodule size≥7cm, multifocal disease and ALB abnormal are potential prognostic factors in cTACE group. SN - 2210-741X UR - https://www.unboundmedicine.com/medline/citation/32593695/Comprehensive_predictive_factors_for_CalliSpheres®_microspheres__CSM__drug_eluting_bead_transarterial_chemoembolization_and_conventional_transarterial_chemoembolization_on_treatment_response_and_survival_in_hepatocellular_carcinoma_patients_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S2210-7401(20)30153-4 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.